A disruptive technology to tackle brain cancer and glioblastoma
News
Patrick Tricoli joins Hemerion as “Strategy & Corporate Development Senior Advisor”
Patrick Tricoli, PharmD, MBA, a long-time Boston resident, is joining our team as Senior Advisor for Strategy & Corporate Development.He brings his in-depth knowledge of the U.S. market and unique… ...
Hemerion Makes Its Debut at the American Association of Neurological Surgeons (AANS) Annual Meeting
Hemerion is participating for the first time in the American Association of Neurological Surgeons (AANS) Annual Meeting, held in San Antonio, Texas, from May 1 to 4, 2026.This major event… ...
Hemerion strengthens its management to accelerate clinical development
After receiving several positive feedback from European and US health agencies, Hemerion is preparing to scale up its teams for the implementation of a pivotal clinical trial, the last step… ...
Stay tuned to our clinical advances
They talk about us
